Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Prev Med ; 155: 106917, 2022 02.
Article in English | MEDLINE | ID: covidwho-1655252

ABSTRACT

Evidence shows that chronic diseases are associated with COVID-19 severity and death. This study aims to estimate the fraction of hospitalizations and deaths from COVID-19 attributable to chronic diseases associated to poor nutrition and smoking among adults who tested positive to COVID-19 in Mexico. We analyzed 1,006,541 adults aged ≥20 who tested positive for COVID-19 from March 23 to December 5, 2020. Six chronic diseases were considered: obesity, chronic obstructive pulmonary disease (COPD), hypertension, diabetes, cardiovascular disease, and chronic kidney disease (CKD). We calibrated the database using a bias quantification method to consider undiagnosed disease cases. To estimate the total impact of multiple diseases, we defined a multimorbidity variable according to the number of diseases. Risks of hospitalization and death were estimated with Poisson regression models and used to calculate population attributable fractions (PAFs). Chronic diseases accounted for to 25.4% [95% CI: 24.8%-26.1%], 28.3% (95% CI: 27.8%-28.7%) and 15.3% (95% CI: 14.9%-15.7%) of the hospitalizations among adults below 40, 40-59, and 60 years and older, respectively. For COVID-19-related deaths, 50.1% (95% CI: 48.6%-51.5%), 40.5% (95% CI: 39.7%-41.3%), and 18.7% (95% CI, 18.0%-19.5%) were attributable to chronic diseases in adults under 40, 40-59, and 60 years and older, respectively. Chronic diseases linked to poor nutrition and smoking could have contributed to a large burden of hospitalization and deaths from COVID-19 in Mexico, particularly among younger adults. Medical and structural interventions to curb chronic disease incidence and facilitate disease control are urgently needed.


Subject(s)
COVID-19 , Pulmonary Disease, Chronic Obstructive , Adult , Aged , Hospitalization , Humans , Risk Factors , SARS-CoV-2
2.
Salud Publica Mex ; 63(6, Nov-Dic): 803-806, 2021 Nov 05.
Article in Spanish | MEDLINE | ID: covidwho-1551992

ABSTRACT

Objetivo. Estimar la seroprevalencia de SARS-CoV-2 en población de edad escolar en México. Material y métodos. Se categorizaron a niños y adolescentes que participaron en la Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19 (Ensanut 2020 Covid-19) por edad escolar y nivel educativo. En participantes seropositivos, se identificó la proporción de infecciones asintomáticas. Se estimaron razones de prevalencia usando un modelo de regresión log-binomial. Resultados. La seroprevalencia en educación básica y media fue de 18.7% (IC95%: 14.9, 22.5) y 26.7% (IC95%: 22.1, 31.3), respectivamente. La infección asintomática fue más frecuente en educación básica (88.5% [IC95%: 80.5, 93.5]). Conclusiones. En población de educación básica la infección por SARS-CoV-2 es baja y usualmente asintomática.


Subject(s)
COVID-19 , SARS-CoV-2 , Adolescent , Child , Humans , Mexico/epidemiology , Schools , Seroepidemiologic Studies
3.
Salud Publica Mex ; 63(6, Nov-Dic): 807-812, 2021 Oct 28.
Article in English | MEDLINE | ID: covidwho-1515709

ABSTRACT

OBJECTIVE: To assess the association of family and housing characteristics with the number of seropositive cases to SARS-CoV-2 in households. MATERIALS AND METHODS: We analyzed 874 households from Encuesta Nacional de Salud y Nutrición (Ensanut) 2020 Covid-19 using Poisson regression models. RESULTS: The number of seropositive family members was higher among families composed of children/adolescents, adults and older adults, households with more than two members per bedroom, and among households with closed windows. No association was found for bathroom availability and piped water. CONCLUSIONS: Family composition and housing characteristics can impose significant structural barriers to safe home confinement.


Subject(s)
COVID-19 , SARS-CoV-2 , Adolescent , Aged , Child , Family , Family Characteristics , Housing , Humans
4.
Salud Publica Mex ; 63(2, Mar-Abr): 225-231, 2021 Feb 26.
Article in Spanish | MEDLINE | ID: covidwho-1310306

ABSTRACT

Objetivo. Determinar el nivel de evidencia sobre la proba-bilidad de transmisión de enfermedades respiratorias agudas en el transporte público colectivo. Material y métodos. Se utilizó la metodología de revisiones rápidas de Cochrane. La estrategia de búsqueda abarcó una base de datos acadé-mica hasta el 10 de diciembre de 2020. Resultados. Se identificaron 16 manuscritos que cumplieron los criterios de selección. En estudios de cohorte agrupados se encontró que el momio de seroconversión por influenza A o B fue 54% mayor en personas con uso frecuente de transporte público colectivo en comparación con las personas con un uso poco frecuente (razón de momios: 1.54; IC95%:1.06-2.01). Conclusión. La probabilidad de contagio por enfermeda-des respiratorias agudas puede incrementar con el uso del transporte público colectivo. Algunas recomendaciones para reducir la probabilidad de contagio en el transporte público colectivo son el uso de cubrebocas y reducir el número de pasajeros y tiempo de traslado.


Subject(s)
Public Sector , Respiratory Tract Infections , Transportation , Humans , Probability , Respiratory Tract Infections/transmission , Transportation/statistics & numerical data
5.
Salud Publica Mex ; 62(3): 319-330, 2020.
Article in Spanish | MEDLINE | ID: covidwho-46170

ABSTRACT

OBJECTIVE: To assess the effectiveness of using surgical masks in community settings to reduce the probability of infection by SARS-CoV-2 or other acute viral respiratory infection, compared to not using surgical masks. MATERIALS AND METHODS: We followed the Cochrane rapid review methodology. The search strategy encompasses one academic database and pre-prints until April 1, 2020. Titles and abstracts were reviewed by one investigator. The full text review was divided among three researchers. The results were synthesized in a narrative way. RESULTS: 713 manuscripts were identified, of which 21 met the inclusion criteria. Of six systematic reviews, four found no reduction in the probability of transmission. Experimental home studies found no differences in the probability of contagion associated with the use of mouth masks. Only one modeling study estimated a 20% reduction in the incidence of acute respiratory disease, assuming that 10 to 50% of the population use the surgical masks correctly. CONCLUSIONS: The scientific evidence is inconclusive to recommend or discourage the use of surgical masks at the population level. Considering the potential negative effects, official recommendations should await for the results of natural experiments currently occurring in countries that have recommended the use of face masks at the population level.


OBJETIVO: Evaluar la efectividad del uso de cubrebocas quirúrgico en ámbitos comunitarios para reducir la probabilidad de contagio por SARS-CoV-2 u otra infección respiratoria aguda viral, en comparación con no usar cubrebocas. MATERIAL Y MÉTODOS: Se utilizó la metodología de revisiones rápidas de Cochrane. La estrategia de búsqueda abarcó una base de datos académica y pre-prints hasta el 1 de abril de 2020. Los títulos y resúmenes fueron revisados por un investigador. La revisión de textos completos fue dividida entre tres investigadores. Los resultados fueron sintetizados de forma narrativa. RESULTADOS: Se identificaron 713 manuscritos, de los cuales 21 cumplieron los criterios de inclusión. De seis revisiones sistemáticas, cuatro no encontraron reducciones en la probabilidad de contagio y seis estudios experimentales en hogares no encontraron diferencias en la probabilidad de contagio asociado con el uso de cubrebocas. Únicamente un estudio de modelaje estimó una reducción de 20% en la incidencia de enfermedad respiratoria, asumiendo que 10 a 50% de la población hace uso correcto de cubrebocas quirúrgicos. CONCLUSIONES: La evidencia científica no es concluyente para recomendar o desalentar el uso de cubrebocas a nivel poblacional. Considerando los potenciales efectos negativos, las recomendaciones gubernamentales deberían esperar a los resultados de los experimentos naturales en países que han recomendado la utilización poblacional de cubrebocas.


Subject(s)
Betacoronavirus , Masks/statistics & numerical data , Pandemics , Respiratory Tract Infections/prevention & control , COVID-19 , Community-Acquired Infections/prevention & control , Community-Acquired Infections/transmission , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Respiratory Tract Infections/transmission , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL